These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 29464529)
1. Prognostic Factors and the Role of Adjuvant Treatment in Periampullary Carcinoma: a Single-Centre Experience of 95 Patients. Baghmar S; Agrawal N; Kumar G; Bihari C; Patidar Y; Kumar S; Chattopadhyay TK; Panda D; Arora A; Pamecha V J Gastrointest Cancer; 2019 Sep; 50(3):361-369. PubMed ID: 29464529 [TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience. Jin Z; Hartgers ML; Sanhueza CT; Shubert CR; Alberts SR; Truty MJ; Muppa P; Nagorney DM; Smyrk TC; Hassan M; Mahipal A Eur J Surg Oncol; 2018 May; 44(5):677-683. PubMed ID: 29506768 [TBL] [Abstract][Full Text] [Related]
3. The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma. Showalter TN; Zhan T; Anne PR; Chervoneva I; Mitchell EP; Yeo CJ; Rosato EL; Kennedy EP; Berger AC J Gastrointest Surg; 2011 Aug; 15(8):1411-6. PubMed ID: 21523621 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma. Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW Clin Transl Oncol; 2012 May; 14(5):391-5. PubMed ID: 22551547 [TBL] [Abstract][Full Text] [Related]
5. The road to tailored adjuvant chemotherapy for all four non-pancreatic periampullary cancers: An international multimethod cohort study. Uijterwijk BA; Lemmers DH; Ghidini M; Wilmink JW; Zaniboni A; Fusai GK; Zerbi A; Koerkamp BG; Luyer M; Ghorbani P; Salvia R; White S; Ielpo B; Goh BKP; Boggi U; Kazemier G; House MG; Mavroeidis VK; Björnsson B; Mazzola M; Serradilla M; Korkolis D; Alseidi A; Roberts KJ; Soonawalla Z; Pessaux P; Fisher WE; Koek S; Kent TS; Vladimirov M; Bolm L; Jamieson N; Dalla Valle R; Kleeff J; Mazzotta A; Suarez Muñoz MA; Cabús SS; Ball CG; Berger AC; Ferarri C; Besselink MG; Hilal MA; Br J Cancer; 2024 Jul; 131(1):117-125. PubMed ID: 38806725 [TBL] [Abstract][Full Text] [Related]
6. Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma. Ecker BL; Vollmer CM; Behrman SW; Allegrini V; Aversa J; Ball CG; Barrows CE; Berger AC; Cagigas MN; Christein JD; Dixon E; Fisher WE; Freedman-Weiss M; Guzman-Pruneda F; Hollis RH; House MG; Kent TS; Kowalsky SJ; Malleo G; Salem RR; Salvia R; Schmidt CR; Seykora TF; Zheng R; Zureikat AH; Dickson PV JAMA Surg; 2019 Aug; 154(8):706-714. PubMed ID: 31141112 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of Palliative Chemotherapy for Ampulla of Vater Adenocarcinoma: A Multicenter Cohort Study. Jang DK; Kim SJ; Chung HH; Lee JM; Yoon SB; Lee JC; Shin DW; Hwang JH; Jung MK; Lee YS; Lee HS; Park JK; Gut Liver; 2024 Jul; 18(4):729-736. PubMed ID: 38130162 [TBL] [Abstract][Full Text] [Related]
9. Clinico-pathological correlates and survival outcomes in 214 resected ampullary adenocarcinomas - are outcomes different in intestinal and pancreatobiliary subtypes with adjuvant gemcitabine? Ramaswamy A; Bhandare M; Bal M; Shrirangwar S; Kataria P; Majumdar S; Swami R; Rohila J; Chaudhari V; Mandavkar S; Chavan N; Shrikhande SV; Ostwal V HPB (Oxford); 2020 Mar; 22(3):376-382. PubMed ID: 31405778 [TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of lymph node status for patients with ampullary adenocarcinoma after radical resection followed by adjuvant treatment. Kwon J; Kim K; Chie EK; Kim BH; Jang JY; Kim SW; Oh DY; Bang YJ Eur J Surg Oncol; 2017 Sep; 43(9):1690-1696. PubMed ID: 28648977 [TBL] [Abstract][Full Text] [Related]
11. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater. Krishnan S; Rana V; Evans DB; Varadhachary G; Das P; Bhatia S; Delclos ME; Janjan NA; Wolff RA; Crane CH; Pisters PW Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):735-43. PubMed ID: 17980502 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the lymph node ratio after resection of periampullary carcinomas. Farid SG; Falk GA; Joyce D; Chalikonda S; Walsh RM; Smith AM; Morris-Stiff G HPB (Oxford); 2014 Jun; 16(6):582-91. PubMed ID: 23777362 [TBL] [Abstract][Full Text] [Related]
14. The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater. Kim ST; Lee J; Lee KT; Lee JK; Lee KH; Choi SH; Heo JS; Choi DW; Park SH; Park JO; Lim HY; Park YS; Kang WK Med Oncol; 2010 Dec; 27(4):1149-54. PubMed ID: 19898973 [TBL] [Abstract][Full Text] [Related]
15. Real-world efficacy and safety of capecitabine with oxaliplatin in patients with advanced adenocarcinoma of the ampulla of Vater. Lee S; Park SJ; Shin K; Hong TH; Kim IH; Lee MA BMC Cancer; 2024 May; 24(1):634. PubMed ID: 38783256 [TBL] [Abstract][Full Text] [Related]
16. Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012. Hester CA; Dogeas E; Augustine MM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Yopp AC J Surg Oncol; 2019 Mar; 119(3):303-317. PubMed ID: 30561818 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemoradiotherapy in periampullary cancers--Where does it stand with conformal radiotherapy: A single institution experience. Kapoor R; Bahl A; Bhattacharyya T; Gupta R; Oinam AS J Cancer Res Ther; 2015; 11(2):433-7. PubMed ID: 26148613 [TBL] [Abstract][Full Text] [Related]
18. Ampullary adenocarcinoma: Defining predictors of survival and the impact of adjuvant therapy following surgical resection for stage I disease. Stiles ZE; Behrman SW; Deneve JL; Glazer ES; Dong L; Wan JY; Martin MG; Dickson PV J Surg Oncol; 2018 Jun; 117(7):1500-1508. PubMed ID: 29518820 [TBL] [Abstract][Full Text] [Related]
19. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience. Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P J BUON; 2016; 21(4):874-882. PubMed ID: 27685908 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer. Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]